These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 9102869)

  • 21. Long-term effects of 1 alpha-hydroxycholecalciferol therapy in chronic hemodialysis patients.
    Rubinger D; Friedlaender MM; Bernheim J; Shachner E; Ronen M; Czaczkes WJ
    Isr J Med Sci; 1982 Oct; 18(10):1019-26. PubMed ID: 7174269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
    Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S
    Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sevelamer reduces calcium load and maintains a low calcium-phosphorus ion product in dialysis patients.
    Gallieni M; Cozzolino M; Carpani P; Zoni U; Brancaccio D
    J Nephrol; 2001; 14(3):176-83. PubMed ID: 11439741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunocorrecting properties and effect on the phosphorus-calcium metabolism of oxidevit (1 alpha-hydroxyvitamin D3)].
    Babarykin DA; Vasipa SB; Gintere GB; Bigestan VIa
    Vopr Med Khim; 1988; 34(4):104-9. PubMed ID: 3195123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
    Bro S; Brandi L; Olgaard K
    Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of efficacy of the phosphate binders nicotinic acid and sevelamer hydrochloride in hemodialysis patients.
    Ahmadi F; Shamekhi F; Lessan-Pezeshki M; Khatami MR
    Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):934-8. PubMed ID: 22982903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of protein and phosphate restricted and calcium and alphacalcidol supplemented diet on renal and parathyroid functions and protein status in chronic renal failure patients.
    Nand N; Aggarwal HK; Anupam ; Sharma M
    J Assoc Physicians India; 1999 Sep; 47(9):869-73. PubMed ID: 10778654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of calcium and phosphorus metabolism in hemodialysis patients in Tehran Province, Iran.
    Mahdavi-Mazdeh M; Zamyadi M; Norouzi S; Heidary Rouchi A
    Iran J Kidney Dis; 2007 Jul; 1(1):25-8. PubMed ID: 19357440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH; Huang TS; Hsieh SJ
    Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of 1 alpha-hydroxycholecalciferol and various dietary phosphorus levels on phosphorus and calcium metabolic indices in rats during hypokinesia].
    Blazheevich NV; Spirichev VB; Ushakov AS; Belakovskiĭ MS; Pozdniakova AL
    Kosm Biol Aviakosm Med; 1982; 16(2):34-40. PubMed ID: 7070035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of CaCO3 alone and CaCO3 plus vitamin D3 in terms of calcium phosphorus product in chronic kidney diseases.
    Adhikary L; Acharya S; Acharya L
    J Nepal Health Res Counc; 2011 Apr; 9(1):67-70. PubMed ID: 22929717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical study of concerning factors of decreased bone mineral content in hemodialysis patients].
    Kohara N
    Nihon Jinzo Gakkai Shi; 1991 Jun; 33(6):587-96. PubMed ID: 1920939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of 1 alpha-OH-D3 on the bone metabolism after high tibial osteotomy].
    Yamashita I; Miyatsu M; Kamo Y; Atsuta Y; Onozawa T
    Nihon Seikeigeka Gakkai Zasshi; 1993 Sep; 67(9):804-15. PubMed ID: 8409641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary hyperparathyroidism in patients on maintenance hemodialysis: study of the N and C-terminal parathyroid hormones.
    Hida M; Shimbo T; Nakamura K; Wakabayashi T; Saitoh H; Satoh T
    Tokai J Exp Clin Med; 1983 Jul; 8(3):225-8. PubMed ID: 6670108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vitamin D receptor gene polymorphism and the rate of bone loss of the femur neck and lumbar spine in hemodialized patients with chronic renal failure].
    Karkoszka H; Chudek J; Strzelczyk P; Wiecek A; Schmidt-Gayk H; Ritz E; Kokot F
    Pol Merkur Lekarski; 1998 Oct; 5(28):199-202. PubMed ID: 10101442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunological and clinical effects of alphacalcidol in patients with psoriatic arthropathy: results of an open, follow-up pilot study.
    Gaál J; Lakos G; Szodoray P; Kiss J; Horváth I; Horkay E; Nagy G; Szegedi A
    Acta Derm Venereol; 2009; 89(2):140-4. PubMed ID: 19325997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of an educational program on calcium and phosphorus metabolism for patients on hemodialysis].
    de Araujo LP; Figueiredo AE; d'Avila DO
    Rev Esc Enferm USP; 2010 Dec; 44(4):928-32. PubMed ID: 21337773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical effects of 25-hydroxycholecalciferol in patients with chronic renal failure.
    Matsushita Y; Hasegawa K; Otomo S; Morii H; Okamoto T
    J Nutr Sci Vitaminol (Tokyo); 1977; 23(3):257-61. PubMed ID: 915557
    [No Abstract]   [Full Text] [Related]  

  • 39. Advantage of hand bone calcium content measurement by local neutron activation analysis for following up hemodialysis patients.
    Kuntz D; Maziere B; Sebert JL; Moriniere P; Meunier PJ; Duquesnoy N; Fournier A
    Nephron; 1983; 34(4):228-33. PubMed ID: 6877458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Alpha-calcidol in the treatment of pseudohypofunction of the parathyroid glands].
    Nizankowska-Błaz T; Korczowski R
    Pol Tyg Lek; 1986 Aug; 41(32):1005-6. PubMed ID: 3774617
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.